Moreland, L W <br/><br/>
Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate.  [electronic resource] 

 -  Arthritis and rheumatism  Nov 1995 
 - 1581-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0004-3591 
<br/><br/><label>Standard No.: </label>10.1002/art.1780381109  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--adverse effects<br/>Arthritis, Rheumatoid--therapy<br/>CD4 Antigens--immunology<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Lymphocyte Subsets--immunology<br/>Male<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Recombinant Fusion Proteins--adverse effects